It was discovered in 1999, after the compound covered in this guide had already been characterized
Rhee CM, Ahmadi SF, Kovesdy CP, Kalantar-Zadeh K
These medications have meaningfully expanded the treatment toolbox for many more patients, Velazquez told Health
It's not a one-size-fits-all approach, and it's not a blanket inclusion or exclusion that, as I described, can send your pharmacy dollars running off the chart
GLP-1 agonists are contraindicated in pregnancy and breastfeeding
There are also a few cautions the FDA notes specific to this drug, including but not limited to: risk of pancreatitis hypoglycemia (low blood sugar) when used in conjunction with certain other drugs renal impairment or kidney failure acute gallbladder disease increased risk of thyroid C-cell tumors The FDA notes that patients who have had, or have family members who have had, medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use liraglutide, nor should individuals who have experienced prior serious hypersensitivity reaction to the drug